← Back to Clinical Trials
Recruiting NCT07062887

Digital Mindfulness for Young Adults With Type 1 Diabetes

Trial Parameters

Condition Type 1 Diabetes (T1D)
Sponsor Yale University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age 30 Years
Start Date 2026-02-04
Completion 2026-09
Interventions
Mindfulness app

Brief Summary

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.

Eligibility Criteria

Inclusion Criteria: 1. Receiving diabetes care at Yale New Haven Children's Hospital or Yale New Haven Hospital. 2. Sign and date informed consent form we will provide 3. Willingness to complete procedures and availability for duration of the study 4. Aged 18-30 years 5. Diagnosed with type 1 diabetes (T1D) or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis) for at least 1 year. 6. User of a continuous glucose monitor (CGM) in your routine clinical care for at least the past 2 weeks. 7. Able to use a smartphone. 8. Able to read and write English. Exclusion Criteria: 1. Current meditation or mindfulness practice meeting or exceeding the study's recommended schedule 2. Current severe untreated psychiatric illness (e.g., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders) or active suicidal ideation 3. New or unstable psychopharmaceutica

Related Trials